RecruitingNCT07165717

A Real World Study of Respiratory Critical Disease.

Sponsor

Ming Zhong

Enrollment

500 participants

Start Date

Mar 1, 2019

Study Type

OBSERVATIONAL

Conditions

Real World Study ARDS (Acute Respiratory Distress Syndrome)

Summary

Acute Respiratory Distress Syndrome (ARDS) is a form of acute diffuse lung injury caused by various etiologies, which rapidly progresses to acute respiratory failure. It is characterized by a sudden onset and severe clinical course. Globally, ARDS affects approximately 3 million individuals each year, accounting for about 10% of admissions to intensive care units (ICUs). Due to the lack of specific pharmacological therapies, mechanical ventilation remains the mainstay of treatment. Therefore, identifying and analyzing prognostic factors for ARDS patients is of great significance for improving patient outcomes and reducing the incidence of poor prognosis.

Eligibility

Min Age: 18 Years

Inclusion Criteria2

Patients with underlying diseases associated with high risk of ARDS, including but not limited to: sepsis, pneumonia, multiple trauma, pulmonary contusion, inhalation injury, massive blood transfusion, other high-risk conditions, or other factors causing excessive respiratory drive.
Patients (or legal representatives) who have provided a signed and dated informed consent form.

Exclusion Criteria6

Age under 18 years.
HIV infection.
Known immunodeficiency disorders (e.g., leukemia, common variable immunodeficiency, etc.).
History of solid organ or bone marrow transplantation.
Receiving treatment with G-CSF or GM-CSF.
Patients with a decision to withdraw from active treatment.

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.